Long-Term Management Vision “Shine through Chemistry. 2030” and Medium-Term Management Plan “Shine through Chemistry. Stage I”
First written in FY2020. 10 of 22 entries say "Restated". Latest entry: FY2026.
The whole theme swung hardest in 2020: 2 of 7 companies on the "Worse" side.
1 other company's latest entry also says "Raised".
- FY2026RaisedAnnual report
「Under the Medium-Term Management Plan covering the fiscal years ending March 2027 through March 2030, the numerical targets for the fiscal year ending March 2030 are net income attributable to owners of the parent of at least ¥20.0 billion, ROS of at least 10%, ROA of at least 7%, and ROE of at least 10%.」
The plan and performance indicators were updated from Stage II targets of net income of ¥17.0 billion and ROE of 10% for the fiscal year ending March 2026 to Stage III targets for the fiscal year ending March 2030 of net income of at least ¥20.0 billion, ROS of at least 10%, ROA of at least 7%, and ROE of at least 10%. The Medium-Term Management Plan, “Shine through Chemistry Stage III” (fiscal years 2026 through 2029), was announced. - FY2026-H1RestatedAnnual report
「Under these circumstances, our group is pursuing the long-term management vision for FY2021–FY2030 and the medium-term management plan for FY2024–FY2026, and is devoting every effort to implementing measures to enhance corporate value.」
The Company continues to advance its Long-Term Management Vision and Medium-Term Management Plan for the fiscal years ending March 2024 through March 2026. - FY2025-H1RestatedAnnual report
「Under these circumstances, our group is pursuing the long-term management vision for FY2021–FY2030 and the medium-term management plan for FY2024–FY2026, and is devoting every effort to implementing measures to enhance corporate value.」
While maintaining its Long-Term Management Vision, the Company continues to advance its Medium-Term Management Plan for the fiscal years ending March 2024 through March 2026. - FY2024RaisedAnnual report
「Under the Medium-Term Management Plan covering the fiscal years ending March 2024 through March 2026, the numerical targets for the fiscal year ending March 2026 are net income attributable to owners of the parent of ¥17.0 billion and ROE (return on equity) of 10%. For the fiscal year under review, net income attributable to owners of the parent was ¥16.612 billion and ROE was 9.3%.」
The target levels were raised from net income of ¥7.0 billion and ROE of 5% under Stage I to net income of ¥17.0 billion and ROE of 10% for the fiscal year ending March 2026 under Stage II. Actual results for the year were net income of ¥16.612 billion and ROE of 9.3%. - FY2024-Q3RestatedAnnual report
「Under these circumstances, our group is pursuing the long-term management vision for FY2021–FY2030 and the new medium-term management plan for FY2024–FY2026, and is devoting every effort to implementing measures to enhance corporate value.」
While maintaining its Long-Term Management Vision, the Company continues to advance its new Medium-Term Management Plan for the fiscal years ending March 2024 through March 2026. - FY2024-Q2ReframedAnnual report
「To improve capital efficiency and enhance shareholder returns by implementing the capital policy established under the Medium-Term Management Plan, “Shine through Chemistry Stage II.”」
The new Medium-Term Management Plan covering the fiscal years ending March 2024 through March 2026 was presented as “Shine through Chemistry Stage II,” and the plan’s capital policy was cited as the basis for the acquisition of treasury shares. - FY2024-Q1ReframedAnnual report
「Under these circumstances, our group is pursuing the long-term management vision for FY2021–FY2030 and the new medium-term management plan for FY2024–FY2026, and is devoting every effort to implementing measures to enhance corporate value.」
The Company changed from its previous Medium-Term Management Plan, “Shine through Chemistry Stage I” (fiscal years ending March 2021 through March 2023), to a new Medium-Term Management Plan covering the fiscal years ending March 2024 through March 2026. The period covered by the Long-Term Management Vision remains unchanged. - FY2023-Q3AdvancedAnnual report
「The group formulated the long-term management vision “Kagaku de, Kagayaku. 2030” and the three-year medium-term management plan “Kagaku de, Kagayaku. Stage I” (fiscal years ending March 2021 to March 2023), and is pursuing initiatives to build a robust business base. Under the plan, the group aims to transform its business portfolio into one that is resilient to changes in the business environment and generates stable earnings by increasing the allocation of resources toward expanding high-value-added businesses and thoroughly improving management efficiency. As part of these initiatives, it signed a share transfer agreement relating to this share transfer.」
As a specific measure to transform its business portfolio, the Company entered into an agreement to transfer all shares of its French consolidated subsidiary Alkaline. - FY2023-Q2RestatedAnnual report
「Under these circumstances, our group is pursuing the long-term management vision for FY2021–FY2030 and the medium-term management plan for FY2021–FY2023, and is devoting every effort to implementing measures to enhance corporate value.」
The Company continues to advance initiatives aligned with its Long-Term Management Vision, “Shine through Chemistry 2030,” and Medium-Term Management Plan, “Shine through Chemistry Stage I.” - FY2023-Q1RestatedAnnual report
「Under these circumstances, our group is pursuing the long-term management vision for FY2021–FY2030 and the medium-term management plan for FY2021–FY2023, and is devoting every effort to implementing measures to enhance corporate value.」
The Company continues to advance the long-term and medium-term plans corresponding to “Chemistry that Shines. 2030” and “Chemistry that Shines. Stage I”. - FY2022AdvancedAnnual report
「The Medium-Term Management Plan announced on 19 May 2020, covering the fiscal years ending March 2021 through March 2023, set numerical targets for net income of ¥7.0 billion and ROE of 5% for the fiscal year ending March 2023. For the fiscal year under review, net income was ¥12.683 billion and ROE was 8.4%. The Company will continue to implement measures to enhance corporate value with full effort toward achieving its targets.」
Against the targets of net income of ¥7.0 billion and ROE of 5% for the fiscal year ending March 2023, actual results for the year were net income of ¥12.683 billion and ROE of 8.4%, exceeding the target levels ahead of the deadline. The disclosure does not state that the plan had been fully achieved. - FY2022-Q3RestatedAnnual report
「Under these circumstances, our group is pursuing the long-term management vision for FY2021–FY2030 and the medium-term management plan for FY2021–FY2023, and is devoting every effort to implementing measures to enhance corporate value.」
The Company continues to advance initiatives aligned with its Long-Term Management Vision, “Shine through Chemistry 2030,” and Medium-Term Management Plan, “Shine through Chemistry Stage I.” - FY2022-Q2RestatedAnnual report
「We are pursuing the long-term management vision for FY2021–FY2030 and the medium-term management plan for FY2021–FY2023, and are devoting every effort to implementing measures to enhance corporate value.」
The Company continues to advance the long-term and medium-term plans corresponding to “Chemistry that Shines. 2030” and “Chemistry that Shines. Stage I”. - FY2022-Q1RestatedAnnual report
「Under these circumstances, our group is pursuing the long-term management vision for FY2021–FY2030 and the medium-term management plan for FY2021–FY2023, and is devoting every effort to implementing measures to enhance corporate value.」
The Company continues to implement measures based on the Long-Term Management Vision and Medium-Term Management Plan. - FY2021AdvancedAnnual report
「The Medium-Term Management Plan for the fiscal years ending March 2021 through March 2023, announced on 19 May 2020, set numerical targets for the fiscal year ending March 2023 of net income of ¥7.0 billion and ROE of 5%. In the consolidated fiscal year, net income was ¥7.36 billion and ROE was 5.1%.」
Against the targets of net income of ¥7.0 billion and ROE of 5% for the fiscal year ending March 2023, actual results for the fiscal year were net income of ¥7.36 billion and ROE of 5.1%. Although the results exceeded the targets numerically before the target deadline, the disclosure does not state that the plan itself had been fully achieved. - FY2021-Q3RestatedAnnual report
「Under these circumstances, our group has formulated a long-term management vision for FY2021–FY2030 and a medium-term management plan for FY2021–FY2023, and is devoting every effort to implementing measures to enhance corporate value.」
The Company reaffirmed the continuation of measures based on the Long-Term Management Vision and Medium-Term Management Plan. - FY2021-Q2RestatedAnnual report
「Under these circumstances, our group has formulated a long-term management vision for FY2021–FY2030 and a medium-term management plan for FY2021–FY2023, and is devoting every effort to implementing measures to enhance corporate value.」
The Company reaffirmed the formulation of the Long-Term Management Vision and Medium-Term Management Plan and the continuation of measures aimed at increasing corporate value. - FY2021-Q1AdvancedAnnual report
「However, after examining the outlook for future demand and the costs required to maintain and renew facilities, the Company determined that it would be difficult to secure earnings over the medium to long term even with further rationalisation. It therefore decided to implement fundamental business-structure reforms, including the suspension of production.」
Regarding the transformation of the business portfolio set out in the Long-Term Management Vision and Medium-Term Management Plan, concrete progress was indicated through the decision to implement fundamental structural reforms, including the suspension of production in the potash business and other operations. - FY2020First statedAnnual report
「The Group will accelerate the expansion of high-value-added businesses and the restructuring of unprofitable businesses, while pursuing thorough management efficiency, and will implement various measures with full commitment to transform its business portfolio into one that generates stable earnings and is resilient to changes in the business environment. These efforts are aimed at achieving the basic strategy of transforming the business structure into a highly efficient one, as set out in the Long-Term Management Vision for the fiscal years ending March 2021 through March 2030 and the Medium-Term Management Plan for the fiscal years ending March 2021 through March 2023. The basic objectives of the Medium-Term Management Plan are to improve asset efficiency, promote an active capital policy, expand high-value-added businesses, and restructure unprofitable businesses. The numerical targets for the fiscal year ending March 2023 are net income of ¥7.0 billion and ROE of 5%.」
New long-term and medium-term plans were disclosed, with net income of ¥7.0 billion and ROE of 5% set as numerical targets for the fiscal year ending March 2023, based on the basic strategy of transforming the business structure into a highly efficient one.